Published in Cancer Weekly, August 31st, 2004
The Sonablate 500, developed by Focus Surgery Inc., Indianapolis, Indiana, is a noninvasive therapy device that uses the power of ultrasound to destroy deep seated tissue without affecting healthy surrounding tissue. Ultrasound energy is non-ionizing "clean energy" that does not affect tissue surrounding the target...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.